LONDON (AP) — Anglo-Swedish drugmaker AstraZeneca says first quarter earnings jumped 74%, buoyed by emerging markets and the success of new cancer treatments. AstraZeneca said Friday that net income rose to $593 million from $340 million in the same period last year.Read more on NewsOK.com